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Abstract
Systematic reviews of existing evidence show promising effects of community health worker
(CHW) programs as a strategy to improve child survival, but also highlight challenges faced by 
CHW programs, including insufficient incentives to deliver timely and appropriate services. We 
assessed the effect of an incentivized community health delivery program in Uganda on all-
cause under-five mortality. A cluster-randomized controlled trial, embedded within the scale-up 
of a new community health delivery program, was undertaken in 214 clusters in 10 districts in
Uganda. In the intervention clusters micro entrepreneur-based community health promoters
(CHPs) were deployed over a three-year period (2011-2013). On average 38 households were 
surveyed in each cluster at the end of 2013, for a total sample size of 8,119 households. The 
primary study outcome was all-cause under-five mortality (U5MR). U5MR was reduced by 27%
(adjusted RR 0.73, 95% CI 0.58-0.93).  
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Abstract 
Background Systematic reviews of existing evidence show promising effects of community 
health worker (CHW) programs as a strategy to improve child survival, but also highlight 
challenges faced by CHW programs, including insufficient incentives to deliver timely and 
appropriate services. We assessed the effect of an incentivized community health delivery 
program in Uganda on all-cause under-five mortality. 
Methods and Findings A cluster-randomized controlled trial, embedded within the scale-up 
of a new community health delivery program, was undertaken in 214 clusters in 10 districts 
in Uganda. In the intervention clusters micro entrepreneur-based community health 
promoters (CHPs) were deployed over a three-year period (2011-2013). On average 38 
households were surveyed in each cluster at the end of 2013, for a total sample size of 8,119 
households. The primary study outcome was all-cause under-five mortality (U5MR). U5MR 
was reduced by 27% (adjusted RR 0.73, 95% CI 0.58-0.93). No harm was reported.  
Limitations Our study had some limitations. First, contamination is plausible because the 
study clusters, within each zone, were geographically close. Second, we rely on retrospective 
recall information. Both of these limitations most likely caused us to estimate a lower bound 
on the treatment effect. Third, the CHPs were blinded to the trial status of the village they 
were assigned to and as a consequence no surveillance and monitoring system was put in 
place in the trial clusters. Mortality rates were calculated based on cross-sectional household 
survey data collected at the end of the trial, thus raising concern that differential in- or out-
migration flows by assignment groups could cause confounding bias in the main mortality 
estimates. However, measured in- and out-migration into the study clusters were similar 
across assignment groups, and baseline household characteristics of the eligible households, 
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and pre-trial infant mortality rates, were not statistically different between the intervention 
group and the control group.  
Conclusion With the accumulated know-how we have today few would question the 
potential of community health care provision. How to best ensure that CHW deliver timely 
and appropriate services is, however, largely an open question and motivates the continued 
search for innovative approaches. We study one such approach which harnesses the power of 
franchised direct selling (business-in-a-bag) to provide community health providers with 
incentives to increase access to low-cost, high-impact health products and free basic newborn 
and child health services. We believe the results are likely to advance a global conversation 
about how to best motivate CHWs to deliver timely and appropriate services.  
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Introduction 
In many developing countries the primary strategy to extend primary health care from 
facilities to underserved rural communities is community health workers (CHW).1 Systematic 
reviews of existing studies show that CHWs can be impactful in promoting positive health 
behavior and in providing basic curative and health services.2-10 The findings from reviews of 
randomized controlled trials of CHW programs and CHW-led interventions, however, are 
mixed.7,9 Two proof-of-principle studies cited as evidence in the WHO and UNICEF home-
visits strategy statement documented large reductions in neonatal mortality (36-54%).11,12 
Four trials delivered in a program setting documented smaller (8-15%), and in three out of 
four trials insignificant, impacts.13-16 Two studies assessed the impact of community-based 
training of mothers, of which one focused on teaching mothers curative treatments of 
malaria17 (40% reduction in under-5 mortality), and one focused on teaching child care to 
expectant and postpartum women18 (no significant impact on neonatal and infant mortality). 
One trial assessed the impact of Integrated Management of Childhood Illness (iMCI) program 
in Bangladesh19, finding no significant effect on under-5 mortality.  
Lack of incentives for CHWs to deliver timely and appropriate services has been 
highlighted as a key challenge in traditional CHW programs.2,3,4,6,10 Specifically, community 
health work is often voluntary, but workers face competing opportunities such as paid-work 
or home production, that may lead them to devote less time to caregiving. This might help 
explain why strong impacts of CHW programs come from studies in settings with high 
quality of supervision and support. Such a monitoring system may not be achievable in 
routine field situations. How to incorporate incentives to motivate CHWs in large-scale CHW 
programs, and the impact that will have, are open questions.  
We assess a community health worker program in Uganda – the community health 
promoter (CHP) program – where community health promoters operate as micro-
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entrepreneurs earning an income on the sale of preventive and curative products to keep them 
motivated and active in the community. The underlying hypothesis was that these incentives, 
coupled with small financial incentives to encourage CHP agents to register pregnant women 
and visit newborns within the first 48 hours of life, would motivate agents to actively provide 
Integrated Community Case Management (iCCM) and Maternal, Newborn and Child Health 
services (MNCH).  
Methods 
Setting and intervention   
In 2007 Living Goods, a US based NGO active in Uganda, in collaboration with BRAC 
Uganda began piloting a new community health delivery model intended to provide iCCM 
and MNCH services. Unlike volunteer-based community health worker programs, the 
community health promoters (CHP) program harnesses the power of franchised direct selling 
to provide CHPs with incentives to increase access to low-cost, high-impact health products 
and basic newborn and child health services. The CHP program was organized into 
geographically based branches, and managed by branch managers and supervised by the two 
NGOs (Living Goods and BRAC Uganda). Each CHP was assigned to a specific cluster, 
which in most cases corresponds to a village. 
 The CHP program is ongoing and by the end of 2013 it was operating in 883 clusters 
(villages), organized in 29 branches, located in 23 districts, spread over all four regions of 
Uganda (see figure 1). Within the next two years, the program is estimated to reach more than 
4000 clusters, organized in 143 branches, with a total population of 4.3 million. 
 
 
 
 
 
 
 
6	  
	  
Fig 1: Map of districts and distribution of clusters 
 
 
Notes: District boundaries underwent repeated modifications in recent years in Uganda. The map refers to the original 
definition of the 56 Districts that was in place until 2005, before the wave of reforms started (there are currently 111 districts 
in the country). Green fully-colored areas indicate districts that were part of the study, while cross-hatched areas indicate 
districts excluded from the study, but in which the program was also implemented. Red and blue dots indicate respectively 
control and intervention villages included in the study. 
 
The CHPs were selected through a competitive process among female community 
members aged 18 to 45 who applied for the position in each village and who possessed basic 
writing and math skills. Eligible candidates received 2 weeks of health and business training, 
covering preventing, diagnosing and treating childhood illness, recognizing danger signs for 
referral, healthy pregnancy and newborn care, and nutrition. At the end of the training, a 
skills test was administered to determine who would become an active CHP. Selected CHPs 
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also attended a one-day training each month to review and refresh key health and business 
topics. 
The CHPs tasks were to conduct home visits, educate households on essential health 
behaviors, provide basic medical advice, referring the more severe cases to the closest health 
center, and to sell preventive and curative health products. The CHPs were also instructed to 
visit newborns within the first 48 hours of life and to encourage pregnant women to deliver in 
a facility or with professional assistance. The product line they had at disposal included 
prevention goods (e.g. insecticide treated bednets, water purification tablets, and vitamins), 
curative treatments (e.g., oral rehydration salts, zinc, and ACTs), as well as other health-
related commodities (e.g. diapers, detergent, and hand soap) and durables with health benefits 
(e.g. improved cook stoves, solar lights, and water filters). These products were sold by the 
CHP at a discount. The retail price was determined by branch managers with a target of 
keeping prices for preventive and curative products at least 20% lower than the prevailing 
local market prices. The CHPs in turn purchased these products directly from Living Goods 
or BRAC branches at wholesale prices between 30-50% below market prices and therefore 
earned an income on each product sold. Thus, the CHPs operated as micro-entrepreneurs with 
financial incentives to meet household demand.  
The broad product mix had three potential benefits: (i) driving up total sales and 
income for the CHPs; (ii) enabling the NGOs to cross-subsidize prices (dropping prices on 
essential health products and increasing the margins on other products); (iii) motivating 
agents to be out visiting households regularly by including high-velocity items like soap and 
fortified foods in the product mix. 
The business training received by the CHPs stressed the importance of building up a 
customer-base by providing free services like health education, referrals, and newborn visits. 
In addition, the CHPs received small performance-based incentives to encourage registering 
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of pregnant women and visits of newborns ($0.65 per registration/newborn visit). In 2012, 
one of the implementers (Living Goods) also began using mobile technology to promote 
coverage and health services.  
Study design and participants 
The study was a parallel-group, stratified cluster randomized controlled trial, embedded in the 
roll-out of the CHP program. 214 clusters (rural villages) took part in the trial. The clusters 
were located in 12 geographical zones spread across Uganda (see figure 1). Within each zone, 
the clusters were randomly divided into an intervention group and a control group. In 11 
zones out of 12 the randomization was balanced (1:1). In one zone and for operational 
purposes the randomization was unbalanced (2:1). A CHP was assigned to each cluster in the 
intervention group. No CHP was assigned to the control clusters. The mean number of 
household per cluster was 237 at baseline.  
The main objective of the trial was to assess the impact on under-five mortality of 
having a CHP working in the cluster. The evaluation design and implementation was 
independent of program implementation. All clusters were enumerated at baseline and a 
smaller household survey was administered to a randomly selected sample of households (on 
average 16 per cluster) to verify balance across assignment groups.  
The outcomes of interest were measured through a cross-sectional household survey 
administered between September and December 2013; approximately three years after the 
CHPs began operating in the intervention clusters. Before implementing the survey, each 
cluster was enumerated. A random computer-generated sequence was then used to select 40 
households to be surveyed in each cluster (if less than 40 eligible households were available, 
all were sampled). Sampled households were visited and asked for written informed consent 
to participate in the survey. Conditional on receiving the consent, an appointment was 
scheduled for the following day. The respondent was the female household head if available 
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at the time of the interview or the primary female health care giver of the household. If 
neither could be found, or the household refused to participate, a replacement household was 
chosen (this happened in 7.2% of the cases, without any systematic difference between 
intervention and control clusters). Random back-checks were performed to ensure that all 
enumerators correctly followed the protocol. No violation was identified. 
The survey was implemented by Innovations for Poverty Action (IPA) Uganda, an 
external organization based in Uganda and specialized in data collection. The survey teams 
were all composed by local staff with previous experience in data collection. Different survey 
teams operated in the different districts covered by the evaluation, to ensure that every staff 
member was familiar with local customs and spoke the local language. Data collectors were 
always masked to whether they were interviewing in an intervention or control cluster. The 
questionnaires were programmed using SurveyCTO-Open Data Kit (ODK), version 1.16. 
Answers to the survey questions were recorded in a digital form and on a daily basis they 
were encrypted and stored on a secure server provided by SurveyCTO. Data were eventually 
combined in one single dataset. 
The trial was embedded in the rollout of the full CHP program (883 clusters) and 
there were no differences in program implementation between the intervention clusters (115 
clusters) and the 768 clusters that were not part of the trial.  
The CHPs were blinded to the trial status of the village they were assigned to avoid 
that the evaluation itself affected the CHPs behavior. As a consequence, no surveillance and 
monitoring system was put in place in the trial clusters and we did not track a pre-determined 
set of households to avoid the CHP focusing their efforts on the households that were tracked 
at the expense of those who were not. Mortality rates were calculated based on cross-
sectional household survey data collected at the end of the trial, using data from households 
that had resided in the same cluster throughout the trial. To ensure that these households were 
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not systematically different in the two assignment groups, we tested for differential in- and 
out-migration during the trial period and checked for balance across assignment groups using 
pre-trial determined observable household characteristics, and pre-trial infant mortality rates, 
collected at the end of the trial period. 
All households and especially households with younger children were potential 
recipients of visits from the CHPs. While the CHPs were recommended to focus attention on 
providing services to households living within their cluster, they were not prevented from 
selling or providing advice also to households outside the cluster, including control clusters. 
Similarly, households living outside the intervention clusters could visit a CHP in an 
intervention cluster.  
Households in both intervention and control clusters could benefit from primary 
health care services provided by other actors, including private clinics, public primary health 
dispensaries and village health teams (a government community health worker program). 
The rollout of the CHP program, including the trial clusters, was overseen by an 
advisory board including individuals with expertise in international public health and health 
service research as well as officials from the Uganda Ministry of Health. The trial was 
approved by the ethic committee of Fondazione IRCSS (D2291696), by the Harvard IRB 
(protocol P20141-101), by the Uganda National Council for Science and Technology 
(UNCST) (SS3195), and by the IRB Office of the Joint Clinical Research Center (JCRC) in 
Uganda. The trial was registered in the Pan African Clinical Trials Registry 
(#PACTR201308000601715) and the registration can be accessed online 
(http://www.pactr.org). 
Randomization and masking  
Figure 2 describes the trial profile. As the full CHP program was rolled out over time, the 
randomization of clusters was also phased in over time. We began in 2009 with a sample of 
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200 clusters (villages) in 10 geographic zones (8 districts). The clusters were stratified by 
zone and village size (below or above 400 villages) and, within each stratum, half of the 
clusters were assigned to the intervention group and half were assigned to the control group 
through a simple randomization procedure (computerized random numbers) generated by the 
researchers using Stata 10 (StataCorp, College Station, TX) statistical software. In 2010, a 
year before the evaluation began; a decision was taken to only include villages with less than 
400 households at baseline as the design of the trial was deemed less suitable for villages 
where the CHPs only would be able to serve a small minority of the households. As a 
consequence, 10 strata with 94 villages (47 intervention and 47 control clusters) were deemed 
ineligible. 60 clusters organized in one new geographic zone were added in the end of 2010. 
Half of these 60 clusters were randomly assigned to the intervention group and half were 
assigned to the control group, following the same procedure adopted for the other zones. An 
additional zone was added in the beginning of 2011. For operational purposes, 1/3 of the 48 
clusters in the final zone were randomly assigned to the control group and the remaining 2/3 
of the clusters were allocated to the intervention group. The final sample for the trial thus 
consisted of 214 villages (115 intervention clusters and 99 control clusters) in 12 zones (10 
districts). The program was fully operational in all intervention clusters in the beginning of 
2011. 
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Fig 2: Trial Profile 
	  
   
Outcomes 
The pre-specified primary outcome was under-five mortality rate (U5MR). Secondary 
outcomes were infant mortality rate (IMR) and neonatal mortality rate (NMR). All mortality 
rates were calculated using the sample household survey data collected at the end of the trial. 
The household survey recorded detailed birth and death information for all children under 
five living in the households at the time of the survey as well as for all children that died 
under the age of five in the previous three years. For each child, we defined the number of 
month of exposure to the risk of death during the trial period, defined as the difference 
between the birth date of the child, or the start date of the trial (January 2011) if the child was 
born before that date, and the date that the child turned five years if that occurred during the 
trial period, or the date of the endline household survey if the child was less than five years 
old at that time, or the date of the death of the child (see Figure S1). Under-five mortality was 
then calculated as number of under-five deaths over the trial period per 1000 child-years of 
Sample (2009-2011): 
      4  Provinces 
   10  Districts 
   12  Branches  
 214  Clusters  
Enrolment	  
Allocation	  
      115 clusters  
  28732 households 
178154 estimated population  
        99 clusters  
  21885 households 
131409 estimated population  
Follow-­‐up	  (2013) 
          0 clusters lost to follow-up 
  31097 households 
    4401 households surveyed     
Analysis: 
    3790 households 
    6192 under-5 children 
      183 under-5 deaths 
 
          0 clusters lost to follow-up 
  23350 households 
    3718 households surveyed 
 Analysis: 
    3228 households 
    5371 under-5 children 
      206 under-5 deaths             
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exposure to the risk of dying under the age of five. Infant mortality was calculated as number 
of deaths during the trial period arising within the first year of life per 1000 infant-years of 
exposure, with infant-years of exposure calculated in a similar way as the child-years of 
exposure to the risk of death. Neonatal mortality was calculated as number of deaths during 
the trial period within the first month of life per 1000 births. 
Additional secondary outcomes of interest were CHP interactions (program 
coverage); follow-up visits; health knowledge, prevention, under-five morbidity (in self-
reported malaria and diarrhea); treatment of under-five children for malaria and diarrhea; 
antenatal, delivery, and postnatal care. Data on all secondary outcomes were collected in the 
endline sample household survey.  
In- and out-migration flows were derived by combining data on the number of 
households residing in cluster 𝑗 at baseline, denoted by 𝑏!, and at the end of the trial, denoted 
by 𝑒!, where subscript 𝑗 refers to a cluster. Under the assumption that the share of households 
that had moved in to cluster 𝑗 during the trial period, out of the total number of households 
sampled for the household survey administered at the end of the trial in cluster 𝑗, 𝜃!,  provides 
an unbiased estimate of the share of households in cluster 𝑗 that moved in to the cluster 
during the trial period, out of the total number of households living in the cluster, 𝜃!, the 
estimated number of households that moved in to cluster 𝑗, denoted 𝑖!, is 𝑖! = 𝜃!×𝑒!, and the 
estimated number of households that moved out, denoted by 𝑜!, is 𝑜! = 𝑏! − (1− 𝜃!)×𝑒!. 
The rate of in-migration is 𝑖!/𝑏! and the rate of out-migration is 𝑜!/𝑏!. 
One change to the secondary outcomes took place during the evaluation. Pneumonia 
was included among the specific diseases targeted by the program. But due to changes in the 
regulatory environment, there was a delay in the authorization to include antibiotics among 
the list of health products provided by the CHPs and pneumonia-related outcomes were 
therefore left out from the evaluation.  
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Statistical analysis 
The sample size was designed to detect a reduction in overall under-five mortality. In a 
community-based trial in 2009 with significant overlap in the regions covered to the CHP 
study, U5MR was 18 deaths per 1000 child-years with a coefficient of variation of the 
incidence rates (k) of 0.32.20 On the basis of these data, and 120 child-years of observations 
in each cluster (three years, 2011-2013, and 40 child observations per year), a sample size of 
214 clusters, of which 115 clusters are allocated to the intervention group and 99 clusters to 
the control group, would detect a 27% reduction in under-five mortality with 80% power at 
the two-sided 5% significance level. 
Intention-to-treat analyses were done to compare intervention and control clusters 
with respect to each outcome. Intention to treat was defined by cluster of residence at 
baseline, as measured in the endline sample household survey. Households that migrated out 
from the baseline cluster were not included in the final analysis, nor were households that 
migrated into the trial clusters.  
For mortality rates we report rate ratios computed using a Poisson model, adjusting 
for the stratified randomized design using binary zone indicators, with the rate ratios derived 
by the use of the marginal standardization technique and the 95% CIs estimated with the delta 
method.21,22 For behavioral outcomes we report risk ratios adjusted for the stratified 
randomized design. Standard errors were clustered at the cluster level to account for intra-
cluster correlation across households located in the same cluster. For in- and out-migration 
flows we report mean differences based on a linear model adjusting for the stratified 
randomized design using binary zone indicators. Stata 12 (Stata Corp, College Station, 
Texas) was used for statistical analysis. 
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Results 
The analysis was based on a sample of 7018 households, and their 11563 under-5 children, 
that have lived in the same cluster throughout the trial.  
Table 1 reports balance tests using baseline data. Baseline characteristics, health 
behavior and morbidity were not systematically different between households in the 
intervention group and the control group.  
Table 1: Baseline characteristics 
 Intervention 
group 
Control group p-value 
A. Clusters    
Number of clusters 115 99  
  Households per cluster 250 (113) 221 (107) 0.226 
  Households with under-5 children per cluster 86 (47) 78 (46) 0.665 
  Distance to main road  5.6 (11.6) 6.8 (12.7) 0.126 
  Distance to electricity transmission line 1.8 (1.5) 1.8 (1.5) 0.707 
  Distance to health center  1.4 (1.1) 1.7 (1.2) 0.256 
  Number of health centers within 5 km 8.3 (5.0) 7.3 (5.2) 0.459 
  Distance to hospital 10.4 (8.5) 11.1 (8.5) 0.916 
B. Households    
Number of household 1755 1763  
  Household size 6.2 (2.8) 6.0 (2.7) 0.118 
  Number of children under-5 in household 1.7 (0.9) 1.7 (0.9) 0.621 
  Number of female under-5 in household 0.88 (0.82) 0.86 (0.80) 0.585 
  Age of children under-5 in household 2.5 (1.1) 2.4 (1.1) 0.070 
  Female household head (FHH): No education 201 (13%) 212 (14%) 0.584 
  FHH: Primary education 721 (48%) 720 (47%) 0.566 
  FHH: Some secondary education 582 (39%) 611 (40%) 0.812 
  Household has cement floor 890 (51%) 915 (52%) 0.930 
  Household has thatched or tile roof 181 (10%) 216 (12%) 0.053 
  Treat water before drinking it 1390 (82%) 1395 (81%) 0.295 
  Slept under a treated mosquito net last night 865 (52%) 870 (52%) 0.898 
  Child affected by malaria (last month) 1281 (43%) 1246 (41%) 0.375 
  Child affected by diarrhea (last month) 523 (18%) 460 (15%) 0.104 
Data are n (%) or mean (SD) from baseline census (for cluster outcomes, panel A) and baseline sample household survey data 
(for household outcomes, panel B). Data for medium and high voltage electricity transmission lines was obtained from the 
Africa electricity transmission network (AICD) study. A variety of sources were consulted to generate the original dataset, 
including documents and maps from national utilities, regional power pools and the World Bank. Health Centers takes into 
account facilities from HCIII (i.e. parish-level health centers, roughly one per 5000 people) and above. Hospitals refer only to 
district/national hospitals (roughly one per 500.000 people). Distance measures are all expressed in kilometers. Shares are 
computed relative to the total valid answers (missing answers are excluded).  
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Detailed data on mortality was not collected at baseline. However, endline data can be 
used to compute infant mortality for the two years preceding the intervention; i.e., in 2009 
and 2010 (Table 2, panel A). IMR was 52.4 per 1000 child-years in the intervention group 
compared to 50.0 per 1000 child-years in the control group (adjusted RR 0.97, 95% CI 0.70-
1.33). 
Table 2: Baseline characteristics of households not lost to follow-up and surveyed at endline 
 Intervention group Control group p-value 
A. Infant mortality    
  Years of exposure to risk of death under 1 year 1927 1743  
  Deaths under 1 year 101 87  
  Mortality rate per 1000 years of exposure 52.4 50.0 0.830 
B. Households    
  Number of household 3787 3217  
  Household size 5.2 (2.3) 5.3 (2.3) 0.518 
  Age household head 36.4 (12.1) 36.7 (12.4) 0.641 
  Years of education household head 8.0 (0.4) 8.0 (0.2) 0.320 
Data are n (%) or mean (SD) from endline sample household survey data for household that have remained in the 
cluster throughout the trial, with values scaled back to baseline period. 
 
Table 3 reports tests on selective in- and out-migration using enumeration data at 
baseline and endline combined with data from the sample household survey. At baseline 
50617 households were residing in the trial cluster, 4132 of whom were estimated to have 
migrated out from the baseline cluster by the end of the trial. The average rate of out-
migration per cluster was 7.1% and was not statistically different between the intervention 
group and control group (p=0.991). An estimated 7962 households moved into the trial 
clusters during the intervention period. The average rate of in-migration per cluster was 
15.3% and was not statistically different between the intervention group and control group 
(p=0.478). The share of sampled households that has moved in to the cluster during the trial 
period, out of the total number of sampled households, was not statistically different between 
the intervention group and control group (p=0.614).  
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Table 3: Population data and flows 
 Intervention group 
(115 clusters) 
Control group 
(99 clusters) p-value 
Rate of in-migration 0.16 (0.12) 0.15 (0.11) 0.478 
Rate of out-migration 0.07 (0.13) 0.07 (0.13) 0.991 
Share of migrants 0.14 (0.09) 0.13 (0.08) 0.614 
Data are mean (SD) estimated by combining data from baseline census, endline census, and endline 
sample household survey. P-values are adjusted for the stratified randomized design. Rate of in-
migration is 𝑖!/𝑏! and rate of out-migration is 𝑜!/𝑏!, where 𝑖! = 𝜃!×𝑒!, 𝑜! = 𝑏! − (1 − 𝜃!)×𝑒!, 𝑏!   is 
number of households residing in cluster j at baseline, 𝑒!   is number of households residing in cluster j 
at endline, and 𝜃! (the share of migrants) is an estimate of the share of households in cluster j that 
moved in to the cluster during the trial period, out of the total number of households living in the 
cluster at endline based on the sample household survey. 
 
 
Panel B of Table 2 shows that pre-trial determined observable household 
characteristics for the households used in the analysis; i.e., household that had remained in 
the same cluster throughout the trial and surveyed in 2013, such as household size at the start 
of the trial and age and years of education of the household head, were not statistically 
different between the intervention group and the control group. Infant mortality (panel A) in 
the two years preceding the intervention was also similar in the intervention and control 
group. 
Table 4 presents adjusted rate ratios describing the impact of the CHP program on the 
primary outcome – child mortality. U5MR was reduced by 27% (adjusted RR 0.73, 95% CI 
0.57-0.93). The RR for IMR corresponds to a 33% reduction in the IMR (adjusted RR 0.67, 
95% CI 0.51-0.87). The RR for NMR implies a 27% reduction in mortality for newborns 
(adjusted RR 0.73, 95% CI 0.55-0.98). 
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Table 4: Under-5 mortality, infant mortality, and neonatal mortality rates 
 Intervention group 
(5894 children) 
Control  group 
(5059 children) 
Adjusted rate 
ratio (95% CI) p value 
Under 5 years     
Years of exposure to risk of death 12294 10731   
Deaths under 5 years 183 206   
Mortality rate per 1000 years of exposure 14.9 19.2 0.73 (0.57 - 0.93)  0.010 
Infants     
Years of exposure to risk of death 3553 3015   
Deaths under 1 year 134 160   
Mortality rate per 1000 years of exposure 37.7 53.1 0.67 (0.51- 0.87)  0.003 
Neonates     
Number of births 3521 2978   
Deaths under 1 month 98 106   
Mortality rate per 1000 births 27.8 35.6 0.73 (0.55 - 0.98)  0.034 
Data are n and mortality rates from endline sample household survey. The number of month of exposure to the risk of death 
during the trial period is used to compute under-5 and infant mortality and is defined as the difference between the birth date of 
the child, or the start date of the trial (January 2011) if the child was born before that date, and the date that the child turned five 
(one for infant mortality) years if that occurred during the trial period, or the date of the endline household survey if the child was 
less than five (one) years old at that time, or the date of the death of the child. Neonatal mortality is calculated as number of 
deaths during the trial period within the first month of life per 1000 births. Adjusted rate ratios are computed using a Poisson 
model, adjusting for stratified randomization. Confidence intervals are constructed using robust standard errors clustered at the 
cluster (village) level. 
 
 
 
The analysis of secondary outcomes (Table 5) showed that 24% of the households in 
the intervention clusters have been visited by a CHP in the 30 days preceding the survey. 
While there was evidence of spillovers – 5% of the households in the control group have also 
been visited by a CHP – households in the intervention group were more than 4 times as 
likely to have benefited from such a visit.  
  
19	  
	  
Table 5: Process indicator outcomes 
  
Intervention group 
(3790 households) 
Control group 
(3228 households) 
Adjusted risk 
ratio (95% CI) 
Household Interaction with CHPs       
Household visited by a CHP in the last 30 days 895/ 3790 (24%) 173/3228 (5%) 4.20 (2.65-6.65) 
Health Knowledge       
Knows diarrhea is transmitted by drinking  
   untreated water 1599/3790 (42%) 1205/3228 (37%) 1.11 (1.04-1.18) 
Believes Zinc is effective in treating diarrhea 954/3790 (25%) 734/3228 (23%) 1.16 (1.05-1.29) 
Mosquito bites are the only cause of malaria 354/3790 (9%) 229/3228 (7%) 1.39 (1.12-1.72) 
Ever heard of food with added vitamins or nutrients 2341/3790 (62%) 1907/3228 (59%) 1.08 (1.02-1.14) 
Believes bednets can help prevent catching malaria  3739/3768 (99%) 3179/3209 (99%) 1.00 (1.00-1.01) 
Believes a woman giving birth should deliver at  
   hospital/facility 
3780/3790 (100%) 
 
3218/3228 (100%) 
 
1.00 (1.00-1.00) 
 
Prevention       
Treat water before drinking it 3067/3786 (81%) 2497/3227 (77%) 1.05 (1.01-1.09) 
Child slept under a treated bednet last night 2395/5894 (41%) 2034/5059 (40%) 1.13 (1.06-1.21) 
Child ever received a Vitamin A dose 4317/5894 (73%) 3692/5059 (73%) 1.00 (0.97-1.03) 
Morbidity and treatment of sick children        
Child sick with malaria during last 3 months  2934/5884 (50%) 2497/5047 (49%) 0.97 (0.92-1.03) 
   Treated with ACT for (at least) 3 days 1940/2927 (66%) 1666/2495 (67%) 1.01 (0.96-1.05) 
Child sick with diarrhea during last 3 months 1482/5885 (25%) 1210/5049 (24%) 1.02 (0.95-1.10) 
   Treated with ORS/Zinc 567/1480 (38%) 395/1206 (33%) 1.16 (1.04-1.30) 
Follow-up, counselling and behavior        
Follow up by after child sick with malaria 401/2881 (14%) 206/2454 (8%) 1.74 (1.38-2.21) 
Follow up by after infant sick with malaria 50/346 (14%) 19/285 (7%) 2.04 (1.16-3.59) 
Follow up after child sick with diarrhea 135/1248 (11%) 68/980 (7%) 1.63 (1.13-2.35) 
Follow up after infant sick with diarrhea 30/213 (14%) 15/195 (8%) 2.13 (1.07-4.20) 
Follow up visit in the first week after delivery 205/1064 (19%) 98/861 (11%) 1.71 (1.31-2.24) 
Advised to give birth with qualified assistance 680/1074 (63%) 501/868 (58%) 1.10 (1.02-1.19) 
Gave birth in a health facility 927/1080 (86%) 740/875 (85%) 1.01 (0.96-1.05) 
Received antenatal care for current pregnancy 215/370 (58%) 205/342 (60%) 0.98 (0.86-1.11) 
Data are n (%) from endline sample household survey. Group assignment is based on the cluster of residence of the household. 
Follow up visits after child/infant sick with malaria/diarrhea for children reported sick in the last 3 months. Follow-up visits in the 
first week after delivery for women that delivered in the last 12 months. Shares are computed relative to the total valid answers 
(missing answers are excluded). Adjusted risk ratios are computed using a Poisson model, adjusting for stratified randomization. 
Confidence intervals are constructed using robust standard errors clustered at the cluster (village) level. 
 
The CHP program resulted in improved health knowledge: households in the 
intervention group were 11% (95% CI 4-18, p=0.001) more likely to know that diarrhea is 
transmitted by drinking untreated water; 16% (95% CI 5-29, p=0.004) more likely to know 
that zinc is effective in treating diarrhea; and 39% (95% CI 12-72, p=0.003) more likely to 
know that mosquito bites are the only cause of malaria. They were also 8% (95% CI 2-14, 
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p=0.004) more likely to have heard of food with added vitamins or nutrients. Knowledge 
about bednets and the importance of professional assistance when giving birth did not differ 
between control and intervention groups. 
The CHP program promoted preventive behavior. Households in the intervention 
group were 5% (95% CI 1-9, p=0.010) more likely to have treated their water before use and 
their children were 13% (95% CI 6-21, p<0.001) more likely to have slept under an 
insecticide-treated bednet.  
Self-reported morbidity in malaria and diarrhea did not differ between control and 
intervention groups. Conditional on falling sick with malaria children in the intervention 
group were as likely as children in the control group to have received treatment with ACTs 
for at least 3 days. Conditional on falling sick with diarrhea children in the intervention group 
were 16% (95% CI 4-30, p=0.008) more likely to have received treatment with ORS/Zinc. 
The largest increases in the intervention relative the control group were observed for 
follow-up visits and counseling. Households with a newborn baby were 71% (95% CI 31-
124, p<0.001) more likely to have received a follow-up visit in the first week after birth, and 
households with a child under-five that fell sick with malaria or diarrhea were, respectively, 
74% (95% CI 38-121, p<0.001) and 63% (95% CI 13-135, p=0.009) more likely to have 
received a follow-up visit. For households with infants that fell sick with malaria or diarrhea 
the increases were 104% (95% CI 16-259, p=0.013) and 113% (95% CI 7-320, p=0.030), 
respectively. A significantly higher share (10%; 95% CI 2-1, p=0.013) of women in the 
intervention group had been advised to give birth with professional assistance, although the 
share that gave birth in a health facility and the share of the currently pregnant women that 
had received at least some antenatal care did not differ between control and intervention 
groups.  
No harm or unintended effect of the intervention was reported.  
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Discussion 
We estimate that the CHP program in Uganda reduced U5MR by 27%, IMR by 33%, and 
NMR by 27% after 3 years. These effects are supported by changes in health knowledge, 
preventive behavior, case management of malaria and diarrhea, and home visits.  
While a growing body of evidence has identified effective interventions that can be 
delivered by community health workers, a key consideration for the success and 
sustainability of such programs is how high-quality performance by community workers can 
be achieved and maintained. This study is the first impact evaluation of a community health 
delivery intervention based on an incentivized approach. Unlike previous studies that have 
primarily focused on the impact of specific interventions that could be delivered effectively 
in a community setting, our focus is on how to ensure that community health workers 
successfully implement a set of interventions proven to be effective if delivered and the 
impact that may have on child health.  
In the CHP program, community health workers operated as micro-entrepreneurs 
earning an income on the sale of preventive and curative products. A concern with such a 
scheme is that it may encourage overuse of medications and inappropriate treatment at the 
expense of prevention and referrals. On the other hand, the provision of free services like 
health education and follow-up visits was viewed as strategy to build up a loyal customer 
base. More generally whether extrinsic incentives in some domains have positive or negative 
impacts on intrinsic motivation in other domains is an empirical question. The data does not 
suggest that the program only had an impact on incentivized services, with evidence of 
increases in the promotion of healthy behavior and changed health beliefs. While there was a 
large increase in visits of newborns, for which the CHPs received a small incentive payment, 
there were also large increases in follow-up visits of children sick in malaria and diarrhea, for 
which no direct incentives were attached.  
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Another concern is that charging for preventive and curative products, even when 
prices are subsidized, will disproportionately benefit the less-poor households. Table S1 
however suggests similar impact across the household wealth distribution.  
The case management of malaria was similar in the intervention and control group. 
Similar treatment pattern does not necessarily imply similar quality of treatment, however. 
The CHPs sell authentic ACT drugs. In the private market there is growing evidence that the 
market for antimalarial medicines is plagued by counterfeit and substandard (fake) products, 
with recent estimates suggesting that as much as a third of the antimalarial drugs sold contain 
too little or no active pharmaceutical ingredients.23 Uganda is no exception: a smaller study 
conducted in the same research areas one year into the program estimated that 37 percent of 
the retail outlets were selling substandard antimalarial drugs.24 Poor quality is not specific to 
ACTs but is a generic problem in the largely unregulated market for preventive and curative 
health products in many developing countries. The CHPs market share for ACT drugs and 
ORS were 11.3% and 14.1% respectively. Under the assumption that every third dose of 
ACT treatment sold in the private market is fake and that authentic drugs are provided in the 
public sector (about 40% of the market share), children in the treatment group are 19% less 
likely to be treated with a fake ACT medicine. 
It is possible that the CHP program affected child mortality not only through the 
provision of iCCM and MNCH services, but also through the subsidized sale of other health-
related commodities and durables (e.g. hand soap, improved cook stoves, fortified food, and 
water filters). The broad product mix, with high-velocity items like soap and fortified foods, 
and low-velocity but high returns per sold unit items improved cook stoves, was deemed 
crucial to motivate agents to be out visiting households regularly and for driving up total 
sales and income for the CHPs. 
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Our study has some limitations. The choice not to have surveillance or monitoring 
systems in place in the study villages implied that we had to rely on retrospective recall 
information. We used standardized data collection methods, and any potential recall lapses 
were expected to affect the intervention and control groups equally and thus lead to an 
attenuation bias that would lead us to estimate a lower bound on the impact of the CHP 
program on child mortality. We also used the end of trial sample survey to define baseline 
residence and thus the core sample for the analysis. Selective out-migration by assignment 
groups could have caused some confounding bias in our main estimates. However, measured 
in- and out-migration into the study clusters were similar across assignment groups (see table 
3) and because baseline household characteristics of the sampled households that had lived in 
the same cluster for the whole study period were not statistically different between the 
intervention group and the control group (see table 2), we are confident that the results were 
not biased. Third, the possibility of contamination is plausible because the study clusters, 
within each zone, were geographically close. Analysis of behavioral data also suggested that 
some contamination occurred, most likely causing us to estimate a lower bound on the impact 
of the CHP program on child mortality.  
With the accumulated know-how we have today few would question the potential of 
community health care provision. How to best ensure that CHW deliver timely and 
appropriate services is, however, largely an open question and motivates the continued search 
for innovative approaches. The CHP program we studied here harnesses the power of 
franchised direct selling (business-in-a-bag) to provide community health providers with 
incentives to increase access to low-cost, high-impact health products and basic newborn and 
child health services. The program is already active in close to 900 villages with a total 
population of 1.3 million and the scale-up is continuing. Within the next two years, the 
program is estimated to reach 4.3 million individuals in more than 4000 clusters. The impact 
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of the CHP program was conditional on existing facility based professional health care as 
availability of referral services is a crucial component to the program. Thus the findings 
should encourage government and non-government organizations to continue improving their 
facility based care but also points to the importance of integrating the program into the 
existing health service provision strategy. The process of integrating the CHP program we 
have evaluated here into the overall community care program is currently underway. 
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Figure A.1a: Arua District   Figure A.1b: Bushenyi (West)/Sheema (East) Districts 
 
Figure A.1c: Jinja district             Figure A.1d: Mbale district 
   
Figure A.1e: Mpigi district              Figure A.1f: Mukono district 
  
Figure A.1g: Pallisa district    Figure A.1h: Ibanda (North)/Mbarara (South) districts  
Notes: These figures are expansions of the map reported in Figure 1. Green fully-colored indicate districts that were part of 
the study. Red and blue dots indicate respectively control and intervention villages included in the study. 
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Figure A.2: Computation of the months of exposure to the risk of death under 5 during the trial period 
Notes: For each child, the number of month of exposure to the risk of death under 5 during the trial period is computed as the 
number of months between the birth date of the child, or the start date of the trial (January 2011) if the child was born before 
that date, and the date that the child turned five years if that occurred during the trial period, or the date of the endline 
household survey if the child was less than five years old at that time, or the date of the death of the child. Figure A.2 
illustrates these different possibilities using the example of three children: child 1 was born before January 2011 and turned 
five years at time C (the same computation would hold if the child died under age 5 at time C). Hence the exposure to the 
risk of death under 5 for child 1 is represented by the (rounded) number of months between January 2011 and time C. Child 
2 was instead born at time A, during the trial period, but died at time D. Hence, in this case the exposure to the risk of death 
under 5 is represented by the (rounded) number of months between time A and D. Finally, child 3 was also born during the 
trial, at time B, and was still alive at the time of the endline. In this case the exposure to the risk of death under 5 is 
represented by the (rounded) number of months between time B and the time of the endline survey. 
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Figure A.3: U5MR in intervention and control zones 
 
 
 
 
Figure A.4: IMR in intervention and control zones 
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Table A.1: Baseline characteristics of households not lost to follow-up and surveyed at endline 
 Intervention group Control group p-value 
A. Infant mortality    
  Years of exposure to risk of death under 1 year 1927 1743  
  Deaths under 1 year 101 87  
  Mortality rate per 1000 years of exposure 52.4 50.0 0.830 
B. Households    
  Number of household 3787 3217  
  Household size 5.2 (2.3) 5.3 (2.3) 0.518 
  Age household head 36.4 (12.1) 36.7 (12.4) 0.641 
  Years of education household head 8.0 (0.4) 8.0 (0.2) 0.320 
Data are n (%) or mean (SD) from endline sample household survey data for household that have remained in the 
cluster throughout the trial, with values scaled back to baseline period. 
 
Table A.2: Under-5 mortality by wealth quartiles 
 Intervention group 
(3790 households) 
Control group 
(3228 households) 
Quartile I    
Years of exposure to risk of death 3547 3120 
Reported deaths under 5 years 57 58 
Mortality rate per 1000 years of exposure 16.1 18.6 
Quartile II    
Years of exposure to risk of death 2918 2750 
Reported deaths under 5 years 42 53 
Mortality rate per 1000 years of exposure 14.4 19.3 
Quartile III    
Years of exposure to risk of death 3075 2500 
Reported deaths under 5 years 42 48 
Mortality rate per 1000 years of exposure 13.7 19.2 
Quartile IV    
Years of exposure to risk of death 2724 2321 
Reported deaths under 5 years 41 45 
Mortality rate per 1000 years of exposure 15.1 19.4 
Data are n and mortality rates from endline sample household survey. Wealth has been computed 
combining eight variables capturing ownership of durable assets (two sets of clothes for each 
household member, mobile phone, radio and television), infrastructure and housing characteristics 
(electricity, roof and floor material) and consumption habits (number of meals containing fish or 
meet served in a week), using Principal Component Analysis (PCA). The wealth index increases 
moving from quartile I to quartile IV. For 22 households asset information is missing. 
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